Concepedia

Han‐Zhong Zhang

HZ

Statistics

Publications

25

Citations

1.6K

H-Index

16

Active since

1989

Affiliations

Maxim Integrated (United States)(Current)

University of Chicago

Shanghai Institute of Organic Chemistry

Central Hospital of Wuhan

Rutgers, The State University of New Jersey

Han‐Zhong Zhang is an author at Maxim Integrated (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

ORCID

Publications per year

1989–2021

25

Publications

25

Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay

Han‐Zhong Zhang, Shailaja Kasibhatla, Yan Wang et al. · Bioorganic & Medicinal Chemistry · 2003 · 235 citations

, , +14

Structure–activity relationships for inhibition of human 5α-reductases by polyphenols

Richard A. Hiipakka, Han‐Zhong Zhang, Wei Dai et al. · Biochemical Pharmacology · 2002 · 214 citations

, , +13

A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid

Shailaja Kasibhatla, Katayoun A. Jessen, Sergei Maliartchouk et al. · Proceedings of the National Academy of Sciences · 2005 · 212 citations

, , +17

Comprehensive definition of genome features in <i>Spirodela polyrhiza</i> by high‐depth physical mapping and short‐read <scp>DNA</scp> sequencing strategies

Todd P. Michael, Douglas W. Bryant, Ryan Gutierrez et al. · The Plant Journal · 2016 · 141 citations · Full text

, , +14

Discovery and SAR of indole-2-carboxylic acid benzylidene-hydrazides as a new series of potent apoptosis inducers using a cell-based HTS assay

Han‐Zhong Zhang, John Drewe, Ben Tseng et al. · Bioorganic & Medicinal Chemistry · 2004 · 96 citations

, , +15

1–5 of 25